Company Overview of Permeon Biologics, Inc.
Permeon Biologics, Inc. develops a panel of human proteins that exhibit potent activity for intracellular biologics in vivo and create active therapeutic agents with potent intracellular activity without cytotoxicity. The company offers Intraphilin Technology Platform to enable intracellular biologics as therapeutic drugs. Its Intraphilin Technology Platform enables intracellular biologics based on identifying naturally occurring human supercharged proteins with an ability to activate cell uptake and permeate to function inside cell cytoplasm and other intracellular compartments to unlock a spectrum of intracellular disease targets and deliver breakthrough therapies for previously untreatabl...
One Kendall Square
Cambridge, MA 02139
Founded in 2008
Key Executives for Permeon Biologics, Inc.
President, Chief Scientific Officer and Director
Scientific Advisory Board Chairman, Board Observer and Founding Scientist
Chief Executive Officer of Permeon Biologics
Compensation as of Fiscal Year 2014.
Permeon Biologics, Inc. Key Developments
Permeon Biologics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Permeon Biologics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries